Department of Surgery, Ulsan University Hospital, 877 Bangeojinsunhwan-doro, Dong-gu, Ulsan 44033, Republic of Korea; University of Ulsan College of Medicine, Ulsan, Republic of Korea.
Department of Surgery, Ulsan University Hospital, 877 Bangeojinsunhwan-doro, Dong-gu, Ulsan 44033, Republic of Korea; University of Ulsan College of Medicine, Ulsan, Republic of Korea.
Transplant Proc. 2022 Jul-Aug;54(6):1627-1631. doi: 10.1016/j.transproceed.2022.03.055. Epub 2022 Jul 7.
Malakoplakia is a rare pseudotumor that arises in the context of recurrent infections, particularly in immunocompromised states. We report a case of renal allograft parenchymal malakoplakia.
A 59-year-old woman successfully received a cadaveric renal transplant in June 2018. Two months after transplantation, she was treated for a urinary tract infection (UTI). In March 2019, she underwent allograft biopsy for increasing creatinine. The biopsy identified T cell mediated rejection and steroid pulse therapy was performed. In December 2019, she was hospitalized for right flank pain and pyuria, and her creatinine level was 1.9 mg/dL. Radiographic findings were suggestive of a hematoma or abscess in the perirenal area, and septated fluid collection was suspected. Biopsy results suggested malakoplakia, and von Kossa stain was positive for Michaelis- Gutmann bodies. Tissue culture demonstrated Escherichia coli, and this was treated with antibiotics. The dose of tacrolimus was reduced. The patient was discharged after 1 month of hospitalization and was maintained on oral antibiotics. Follow-up imaging revealed an increase in the extent of lesion into the adjacent abdominal wall. Assuming the case to be refractory, we performed surgical resection and abscess drainage. Although the renal parenchymal involvement persisted, the size showed a decreasing trend over 2 months of serial observation with ultrasonography.
Malakoplakia should be considered as a differential diagnosis for recurrent UTI with graft dysfunction. Malakoplakia can be successfully treated with reduction in immunosuppression and medical therapy using long-term antibiotic treatment in most cases. However, early surgical treatment must be considered for refractory cases.
黏膜相关样包涵体病是一种罕见的假瘤,发生于反复感染的背景下,尤其是在免疫功能低下的情况下。我们报告一例肾移植实质黏膜相关样包涵体病。
一名 59 岁女性于 2018 年 6 月成功接受了尸体肾移植。移植后 2 个月,她因尿路感染(UTI)接受治疗。2019 年 3 月,她因肌酐升高接受了移植肾活检。活检结果提示 T 细胞介导的排斥反应,并进行了类固醇脉冲治疗。2019 年 12 月,她因右侧腰痛和脓尿住院,肌酐水平为 1.9mg/dL。影像学检查结果提示肾周区域血肿或脓肿,怀疑有分隔积液。活检结果提示黏膜相关样包涵体病,迈克尔-古特曼体的 von Kossa 染色阳性。组织培养显示大肠埃希菌,并用抗生素治疗。他克莫司的剂量减少。患者住院 1 个月后出院,并继续口服抗生素。随访影像学检查显示病变范围扩大至邻近腹壁。考虑到该病例为难治性,我们进行了手术切除和脓肿引流。虽然肾实质受累持续存在,但在超声连续观察 2 个月后,大小呈下降趋势。
对于复发性 UTI 伴移植物功能障碍,应考虑黏膜相关样包涵体病作为鉴别诊断。在大多数情况下,减少免疫抑制和使用长期抗生素治疗可以成功治疗黏膜相关样包涵体病。然而,对于难治性病例,必须早期考虑手术治疗。